https://orcid.org/0000-0003-2505-0066
Figures & data
Table 1. Patient and treatment characteristics of patients diagnosed with pancreatic ductal adenocarcinoma in the Netherlands in 2015 until 2018 (n = 10,298).
Figure 1. (A) Overall survival of the total cohort (n = 10,298). (B) Overall survival in patients who underwent immediate resection of the primary tumour (n = 1339). (C) Overall survival of patients who received chemotherapy, without resection (n = 2266). (D) Overall survival of patients who received no anticancer treatment (n = 6349).
Figure 2. Overall survival of patients <60 years old diagnosed in an academic hospital vs. diagnosed in a non-academic hospital (n = 1551).
Table 2. Multivariable Cox proportional hazards model of patients diagnosed with pancreatic cancer at <60 years in the Netherlands from 2015 until 2018 (n = 1551).
Figure 3. Overall survival of patients <50 years old vs. patients 51–59 years old (n = 1551).
Table 3. Patient and treatment characteristics of patients with pancreatic ductal adenocarcinoma aged 51–59 years old compared to patients <50 years old at time of diagnosis in the Netherlands in 2015 until 2018 (n = 1551).